Global Biopharmaceutical Industry Commitment to Address Coronavirus Public Health Crisis
As part of the global health community, biopharmaceutical companies are committed to playing the greatest possible role in the global response to COVID-19.
Our members have a breadth of expertise (research, clinical development, manufacturing) that uniquely positions our industry to support the fight against the spread of COVID-19. We have a strong sense of responsibility to act together, as well as in partnership with the World Health Organization (WHO), governments and health systems across the world in a concerted, collective response.
Already, our industry has responded on an unprecedented scale to the current pandemic.
Download this statement to see the 7 commitments the industry is making to address the Coronavirus public health crisis.
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
